Literature DB >> 9651386

Differential expression of agrin in renal basement membranes as revealed by domain-specific antibodies.

C J Raats1, M A Bakker, W Hoch, W P Tamboer, A J Groffen, L P van den Heuvel, J H Berden, J van den Born.   

Abstract

We determined the specificity of two hamster monoclonal antibodies and a sheep polyclonal antiserum against heparan sulfate proteoglycan isolated from rat glomerular basement membrane. The antibodies were characterized by enzyme-linked immunosorbent assay on various basement membrane components and immunoprecipitation with heparan sulfate proteoglycan with or without heparitinase pre-treatment. These experiments showed that the antibodies specifically recognize approximately 150-, 105-, and 70-kDa core proteins of rat glomerular basement membrane heparan sulfate proteoglycan. Recently, we showed that agrin is a major heparan sulfate proteoglycan in the glomerular basement membrane (Groffen, A. J. A., Ruegg, M. A., Dijkman, H. B. P. M., Van der Velden, T. J., Buskens, C. A., van den Born, J., Assmann, K. J. M., Monnens, L. A. H., Veerkamp, J. H., and van den Heuvel, L. P. W. J. (1998) J. Histochem. Cytochem. 46, 19-27). Therefore, we tested whether our antibodies recognize agrin. To this end, we evaluated staining of Chinese hamster ovary cells transfected with constructs encoding full-length or the C-terminal half of rat agrin by analysis on a fluorescence-activated cell sorter. Both hamster monoclonals and the sheep antiserum clearly stained cells transfected with the construct encoding full-length agrin, whereas wild type cells and cells transfected with the construct encoding the C-terminal part of agrin were not recognized. A panel of previously characterized monoclonals, directed against C-terminal agrin, clearly stained cells transfected with either of the constructs but not wild type cells. This indicates that both hamster monoclonals and the sheep antiserum recognize epitopes on the N-terminal half of agrin. By immunohistochemistry on rat renal tissue, we compared distribution of N-terminal agrin with that of C-terminal agrin. The monoclonal antibodies against C-terminal agrin stained almost exclusively the glomerular basement membrane, whereas the anti-N-terminal agrin antibodies recognized all renal basement membranes, including tubular basement membranes. Based on these results, we hypothesize that full-length agrin is predominantly expressed in the glomerular basement membrane, whereas in most other renal basement membranes a truncated isoform of agrin is predominantly found that misses (part of) the C terminus, which might be due to alternative splicing and/or posttranslational processing. The possible significance of this finding is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9651386     DOI: 10.1074/jbc.273.28.17832

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.

Authors:  Tom Nijenhuis; Alexis J Sloan; Joost G J Hoenderop; Jan Flesche; Harry van Goor; Andreas D Kistler; Marinka Bakker; Rene J M Bindels; Rudolf A de Boer; Clemens C Möller; Inge Hamming; Gerjan Navis; Jack F M Wetzels; Jo H M Berden; Jochen Reiser; Christian Faul; Johan van der Vlag
Journal:  Am J Pathol       Date:  2011-08-11       Impact factor: 4.307

2.  The tetraspanin CD37 protects against glomerular IgA deposition and renal pathology.

Authors:  Angelique L Rops; Carl G Figdor; Alie van der Schaaf; Wim P Tamboer; Marinka A Bakker; Jo H Berden; Henry B P M Dijkman; Eric J Steenbergen; Johan van der Vlag; Annemiek B van Spriel
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 3.  Glomerular basement membrane heparan sulfate in health and disease: A regulator of local complement activation.

Authors:  Dorin-Bogdan Borza
Journal:  Matrix Biol       Date:  2016-09-06       Impact factor: 11.583

4.  Defects in eye development in transgenic mice overexpressing the heparan sulfate proteoglycan agrin.

Authors:  Peter G Fuerst; Steven M Rauch; Robert W Burgess
Journal:  Dev Biol       Date:  2006-12-02       Impact factor: 3.582

5.  Central role for melanocortin-4 receptors in offspring hypertension arising from maternal obesity.

Authors:  Anne-Maj S Samuelsson; Amandine Mullier; Nuria Maicas; Nynke R Oosterhuis; Sung Eun Bae; Tatiana V Novoselova; Li F Chan; Joaquim M Pombo; Paul D Taylor; Jaap A Joles; Clive W Coen; Nina Balthasar; Lucilla Poston
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-06       Impact factor: 11.205

6.  Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathies.

Authors:  C J Raats; J van den Born; M A Bakker; B Oppers-Walgreen; B J Pisa; H B Dijkman; K J Assmann; J H Berden
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

7.  Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice.

Authors:  Steven M Rauch; Kathy Huen; Miles C Miller; Hira Chaudry; Melissa Lau; Joshua R Sanes; Conrad E Johanson; Edward G Stopa; Robert W Burgess
Journal:  J Neuropathol Exp Neurol       Date:  2011-12       Impact factor: 3.685

Review 8.  New role for Agrin in T cells and its potential importance in immune system regulation.

Authors:  Elizabeth C Jury; Panagiotis S Kabouridis
Journal:  Arthritis Res Ther       Date:  2010-04-12       Impact factor: 5.156

9.  Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats.

Authors:  Heleen Rienstra; Kirankumar Katta; Johanna W A M Celie; Harry van Goor; Gerjan Navis; Jacob van den Born; Jan-Luuk Hillebrands
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

10.  Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity.

Authors:  Scott J Harvey; George Jarad; Jeanette Cunningham; Angelique L Rops; Johan van der Vlag; Jo H Berden; Marcus J Moeller; Lawrence B Holzman; Robert W Burgess; Jeffrey H Miner
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.